CA2259967C - Reactif de peptides permettant la detection de cytomegalovirus (cmv) humain - Google Patents

Reactif de peptides permettant la detection de cytomegalovirus (cmv) humain Download PDF

Info

Publication number
CA2259967C
CA2259967C CA002259967A CA2259967A CA2259967C CA 2259967 C CA2259967 C CA 2259967C CA 002259967 A CA002259967 A CA 002259967A CA 2259967 A CA2259967 A CA 2259967A CA 2259967 C CA2259967 C CA 2259967C
Authority
CA
Canada
Prior art keywords
cmv
peptide
seq
antibodies
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002259967A
Other languages
English (en)
Other versions
CA2259967A1 (fr
Inventor
Jaap Michiel Middeldorp
Johannes Martinus Gerardus Van De Crommert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Priority claimed from PCT/EP1997/003717 external-priority patent/WO1998002746A1/fr
Publication of CA2259967A1 publication Critical patent/CA2259967A1/fr
Application granted granted Critical
Publication of CA2259967C publication Critical patent/CA2259967C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne un réactif de peptides comprenant des peptides immunochimiquement réactifs avec des anticorps au cytomégalovirus (CMV) humain. L'invention concerne également de nouveaux anticorps dirigés contre ces peptides ou des fragments de ces peptides, ainsi que des lignées cellulaires capables de produire des anticorps monoclonaux. L'invention concerne aussi un procédé de détection de CMV ou d'anticorps dirigés contre le CMV dans un fluide d'essai et un kit d'essai à utiliser dans l'application de ces procédés de détection. L'invention concerne enfin la détection de CMV dans un fluide d'essai ou un prélèvement tissulaire en utilisant des anticorps, monoclonaux et polyclonaux, dirigés contre ces peptides, anticorps qui ont la caractéristique de détecter des protéines de CMV endogènes et des protéines de CMV dénaturées.
CA002259967A 1996-07-12 1997-07-09 Reactif de peptides permettant la detection de cytomegalovirus (cmv) humain Expired - Lifetime CA2259967C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96201972 1996-07-12
EP96201972.5 1996-07-12
PCT/EP1997/003717 WO1998002746A1 (fr) 1996-07-12 1997-07-09 Reactif de peptides permettant la detection de cytomegalovirus (cmv) humain

Publications (2)

Publication Number Publication Date
CA2259967A1 CA2259967A1 (fr) 1998-01-22
CA2259967C true CA2259967C (fr) 2006-04-11

Family

ID=36178213

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002259967A Expired - Lifetime CA2259967C (fr) 1996-07-12 1997-07-09 Reactif de peptides permettant la detection de cytomegalovirus (cmv) humain

Country Status (1)

Country Link
CA (1) CA2259967C (fr)

Also Published As

Publication number Publication date
CA2259967A1 (fr) 1998-01-22

Similar Documents

Publication Publication Date Title
AU666920B2 (en) Peptides and nucleic acid sequences related to the Epstein Barr virus
JP4612071B2 (ja) エプスタイン−バールウイルスペプチド及び該ペプチドに対する抗体
EP0960336B1 (fr) Reactif de peptides permettant la detection de cytomegalovirus (cmv) humain
JP4957974B2 (ja) エプスタイン・バールウイルスのペプチド及びこれらのペプチドに対する抗体
CA2259967C (fr) Reactif de peptides permettant la detection de cytomegalovirus (cmv) humain
US6365717B1 (en) Peptides and nucleic acid sequences related to the Epstein Barr virus
Williamson et al. Use of recombinant human antibody fragments for detection of cytomegalovirus antigenemia

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170710